Clinical outcome trial with IV iron in patients with iron deficiency, stabilized after acute HF

Clinical outcome trial with IV iron in patients with iron deficiency stabilized after acute HF
3' education - Dec. 15, 2020 - Prof. Peter van der Meer, MD, PhD
  • Overview

    In the AFFIRM-AHF trial, the effect of administration of IV ferric carboxymaltose at hospital discharge on hard outcomes was examined in patients stabilized after an acute HF episode and concomitant iron deficiency.

  • Educational information

    This video was recorded after the results of the AFFIRM-AHF trial were presented at AHA 2020.

  • Faculty

    Prof. Peter van der Meer, MD is cardiologist at the University Medical Center Groningen in the Netherlands.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    Read our summary of this trial Watch another video on the AFFIRM-AHF trial

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free